Integra LifeSciences Corp. regulatory update

IART received U.S. Patent Nos. 5,770,565 and 5,792,745 covering the use of compounds based on the arginine-glycine-aspartic (RGD) amino acid sequence to reduce or inhibit bone resorption. The company ...